跳至主要内容
临床试验/NCT06196307
NCT06196307
招募中
不适用

A Prospective Study of Acute Nontraumatic Chest Pain - Warning and Classification

Xiao-nan He1 个研究点 分布在 1 个国家目标入组 10,000 人2022年8月30日

概览

阶段
不适用
干预措施
Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization
疾病 / 适应症
Chest Pain
发起方
Xiao-nan He
入组人数
10000
试验地点
1
主要终点
Adverse events
状态
招募中
最后更新
2个月前

概览

简要总结

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

详细描述

Prospective observational studies used outpatient and follow-up information to construct an auxiliary early warning model of acute non-traumatic chest pain based on federated learning, and optimized the accuracy of early warning models through retrospective and prospective studies of large cohort data, and established an efficient and stable early warning and classification model for acute non-traumatic chest pain.

注册库
clinicaltrials.gov
开始日期
2022年8月30日
结束日期
2028年12月30日
最后更新
2个月前
研究类型
Observational
性别
All

研究者

发起方
Xiao-nan He
责任方
Sponsor Investigator
主要研究者

Xiao-nan He

Chief physician of Emergency and Critical Care Center of Beijing Anzhen Hospital

Beijing Anzhen Hospital

入排标准

入选标准

  • Age ≥ 18 years
  • Symptom onset or worsening within 24 hours before presentation, with a chief complaint of acute chest pain meeting the broad definition of chest pain (2021 AHA)
  • Presentation to the emergency department, with a clinical diagnosis consistent with non-traumatic chest pain
  • Signed informed consent

排除标准

  • traumatic chest pain
  • systemic pain caused by malignant tumors or rheumatic diseases involving the chest
  • Patients were lost to follow-up

研究组 & 干预措施

No cardiovascular adverse and cerebrovascular events (MACCE) occurred during the 1-month period

No cardiovascular and cerebrovascular adverse events (MACCE),which included cardiovascular death, all-cause mortality, nonfatal myocardial infarction, refractory angina, new onset heart failure and stroke. Follow-up visits are conducted by in-person or telephone and registration is carried out.

干预措施: Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

Group of major cardiovascular and cerebrovascular adverse events (MACCE) occurring during 1 month

Cardiovascular and cerebrovascular adverse events occur, the rest of the same as in the previous group

干预措施: Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

结局指标

主要结局

Adverse events

时间窗: 30 days after presenting to the emergency departments(ED)

The primary outcome was a composite of adjudicated major adverse cardiovascular and cerebrovascular events (MACCE), which included cardiovascular death, all-cause mortality, nonfatal myocardial infarction, refractory angina, new onset heart failure and stroke.

研究点 (1)

Loading locations...

相似试验